447 related articles for article (PubMed ID: 22124278)
21. Fluorescent hollow/rattle-type mesoporous Au@SiO2 nanocapsules for drug delivery and fluorescence imaging of cancer cells.
Wang TT; Chai F; Wang CG; Li L; Liu HY; Zhang LY; Su ZM; Liao Y
J Colloid Interface Sci; 2011 Jun; 358(1):109-15. PubMed ID: 21453927
[TBL] [Abstract][Full Text] [Related]
22. A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance.
He Q; Gao Y; Zhang L; Zhang Z; Gao F; Ji X; Li Y; Shi J
Biomaterials; 2011 Oct; 32(30):7711-20. PubMed ID: 21816467
[TBL] [Abstract][Full Text] [Related]
23. pH-Dependent doxorubicin release from terpolymer of starch, polymethacrylic acid and polysorbate 80 nanoparticles for overcoming multi-drug resistance in human breast cancer cells.
Shalviri A; Raval G; Prasad P; Chan C; Liu Q; Heerklotz H; Rauth AM; Wu XY
Eur J Pharm Biopharm; 2012 Nov; 82(3):587-97. PubMed ID: 22995704
[TBL] [Abstract][Full Text] [Related]
24. pH-sensitive poly(glutamic acid) grafted mesoporous silica nanoparticles for drug delivery.
Zheng J; Tian X; Sun Y; Lu D; Yang W
Int J Pharm; 2013 Jun; 450(1-2):296-303. PubMed ID: 23598077
[TBL] [Abstract][Full Text] [Related]
25. Bioactive silica-based drug delivery systems containing doxorubicin hydrochloride: in vitro studies.
Prokopowicz M; Zegliński J; Gandhi A; Sawicki W; Tofail SA
Colloids Surf B Biointerfaces; 2012 May; 93():249-59. PubMed ID: 22325320
[TBL] [Abstract][Full Text] [Related]
26. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
[TBL] [Abstract][Full Text] [Related]
27. Electrospun upconversion composite fibers as dual drugs delivery system with individual release properties.
Hou Z; Li X; Li C; Dai Y; Ma P; Zhang X; Kang X; Cheng Z; Lin J
Langmuir; 2013 Jul; 29(30):9473-82. PubMed ID: 23855606
[TBL] [Abstract][Full Text] [Related]
28. Redox-responsive mesoporous silica nanoparticles: a physiologically sensitive codelivery vehicle for siRNA and doxorubicin.
Ma X; Teh C; Zhang Q; Borah P; Choong C; Korzh V; Zhao Y
Antioxid Redox Signal; 2014 Aug; 21(5):707-22. PubMed ID: 23931896
[TBL] [Abstract][Full Text] [Related]
29. Fabrication of hollow and porous structured GdVO4:Dy3+ nanospheres as anticancer drug carrier and MRI contrast agent.
Kang X; Yang D; Ma P; Dai Y; Shang M; Geng D; Cheng Z; Lin J
Langmuir; 2013 Jan; 29(4):1286-94. PubMed ID: 23281806
[TBL] [Abstract][Full Text] [Related]
30. Luminescent mesoporous nanoreservoirs for the effective loading and intracellular delivery of therapeutic drugs.
Kwon S; Singh RK; Kim TH; Patel KD; Kim JJ; Chrzanowski W; Kim HW
Acta Biomater; 2014 Mar; 10(3):1431-42. PubMed ID: 24239681
[TBL] [Abstract][Full Text] [Related]
31. Novel folated and non-folated pullulan bioconjugates for anticancer drug delivery.
Scomparin A; Salmaso S; Bersani S; Satchi-Fainaro R; Caliceti P
Eur J Pharm Sci; 2011 Apr; 42(5):547-58. PubMed ID: 21371555
[TBL] [Abstract][Full Text] [Related]
32. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
Ma X; Zhao Y; Ng KW; Zhao Y
Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
[TBL] [Abstract][Full Text] [Related]
33. Effect of pH-responsive alginate/chitosan multilayers coating on delivery efficiency, cellular uptake and biodistribution of mesoporous silica nanoparticles based nanocarriers.
Feng W; Nie W; He C; Zhou X; Chen L; Qiu K; Wang W; Yin Z
ACS Appl Mater Interfaces; 2014 Jun; 6(11):8447-60. PubMed ID: 24745551
[TBL] [Abstract][Full Text] [Related]
34. Controlled intracellular release of doxorubicin in multidrug-resistant cancer cells by tuning the shell-pore sizes of mesoporous silica nanoparticles.
Gao Y; Chen Y; Ji X; He X; Yin Q; Zhang Z; Shi J; Li Y
ACS Nano; 2011 Dec; 5(12):9788-98. PubMed ID: 22070571
[TBL] [Abstract][Full Text] [Related]
35. A reduction-sensitive carrier system using mesoporous silica nanospheres with biodegradable polyester as caps.
He H; Kuang H; Yan L; Meng F; Xie Z; Jing X; Huang Y
Phys Chem Chem Phys; 2013 Sep; 15(34):14210-8. PubMed ID: 23880907
[TBL] [Abstract][Full Text] [Related]
36. Mesoporous silica nanoparticles loading doxorubicin reverse multidrug resistance: performance and mechanism.
Shen J; He Q; Gao Y; Shi J; Li Y
Nanoscale; 2011 Oct; 3(10):4314-22. PubMed ID: 21892492
[TBL] [Abstract][Full Text] [Related]
37. Biodegradable click capsules with engineered drug-loaded multilayers.
Ochs CJ; Such GK; Yan Y; van Koeverden MP; Caruso F
ACS Nano; 2010 Mar; 4(3):1653-63. PubMed ID: 20201548
[TBL] [Abstract][Full Text] [Related]
38. Mesoporous silica coated gold nanorods loaded doxorubicin for combined chemo-photothermal therapy.
Monem AS; Elbialy N; Mohamed N
Int J Pharm; 2014 Aug; 470(1-2):1-7. PubMed ID: 24792973
[TBL] [Abstract][Full Text] [Related]
39. A magnetic, luminescent and mesoporous core-shell structured composite material as drug carrier.
Yang P; Quan Z; Hou Z; Li C; Kang X; Cheng Z; Lin J
Biomaterials; 2009 Sep; 30(27):4786-95. PubMed ID: 19520428
[TBL] [Abstract][Full Text] [Related]
40. Dual-mode tracking of tumor-cell-specific drug delivery using fluorescence and label-free SERS techniques.
Yang J; Wang Z; Zong S; Chen H; Zhang R; Cui Y
Biosens Bioelectron; 2014 Jan; 51():82-9. PubMed ID: 23939474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
